Lung Cancers Active Not Recruiting Phase 1 / 2 Trials for Ibrutinib (DB09053)

Back to Lung Cancers

Also known as: Cancer, Lung / Lung Cancer / Lung cancer NOS / Primary malignant neoplasm of lung (disorder) / Lung neoplasm malignant / Cancer of lung / Ca lung / Malignant tumor of lung (disorder)

Indication	Status	Phase
DBCOND0072929 (Lung Cancers)	Active Not Recruiting	1 / 2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT02321540	A Phase I/II Study of Ibrutinib in Previously Treated Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer	Treatment	Ibrutinib (DB09053)